NCT06097065View on ClinicalTrials.gov

Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.

RecruitingOBSERVATIONAL
Enrollment

2,860

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
PrediabetesDiabetes MellitusGestational Diabetes MellitusProteomics
Interventions
DIAGNOSTIC_TEST

Oral Glucose Tolerance Test

Grouping based on detected oral glucose tolerance test results without any other intervention.

Trial Locations (1)

510000

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Zhujiang Hospital

OTHER